Published on 24 May 2024 on Simply Wall St. via Yahoo Finance
Individual investors own 24% of AC Immune SA (NASDAQ:ACIU) shares but private equity firms control...
Key Insights
The considerable ownership by private equity firms in AC Immune indicates that they collectively have a greater say in management and business strategyThe top 4 shareholders own 53% of the company Institutions own 18% of AC Immune
A look at the shareholders of AC Immune SA (NASDAQ:ACIU) can tell us which group is most powerful. We can see that private equity firms own the lion's share in the company with 30% ownership. Put another way, the group faces the maximum upside potential (or downside risk).